Zhi Shi, Ph.D.

2002 University of Southern California, Los Angeles, CA, United States 
"Zhi Shi"


Sign in to add mentor
C.-C. Jay Kuo grad student 2002 USC
 (Theory and applications of bandwidth-efficient scheduling for multicast on -demand services.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shi ZQ, Ji NN, Hu HL. (2020) One-pot concomitant preparation of two copper(II) coordination polymers with different configurations of bridging bithiophene ligands. Acta Crystallographica. Section C, Structural Chemistry. 76: 37-43
Zhou HH, Chen X, Cai LY, et al. (2019) Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer. Frontiers in Oncology. 9: 1398
Nan XW, Gong LH, Chen X, et al. (2019) Survivin Promotes Piperlongumine Resistance in Ovarian Cancer. Frontiers in Oncology. 9: 1345
Li P, Lin XJ, Yang Y, et al. (2019) Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma. Cell Death & Disease. 10: 916
Zhang W, Yang Y, Dong Z, et al. (2019) SNPs in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of ER and reduce cell resistance to anticancer drugs. The Journal of Biological Chemistry
Cheng YW, Kong XW, Wang N, et al. (2019) Thymol confers tolerance to salt stress by activating anti-oxidative defense and modulating Na homeostasis in rice root. Ecotoxicology and Environmental Safety. 188: 109894
Shi Z, Guo HQ, Cohen PA, et al. (2019) Editorial: Novel Targets and Biomarkers in Solid Tumors. Frontiers in Pharmacology. 10: 828
Huang SZ, Wei MN, Huang JR, et al. (2019) Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma. Frontiers in Oncology. 9: 150
Wang K, Xing ZH, Jiang QW, et al. (2019) Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance. Frontiers in Oncology. 9: 80
Xu LN, Zhao N, Chen JY, et al. (2019) Celastrol Inhibits the Growth of Ovarian Cancer Cells and . Frontiers in Oncology. 9: 2
See more...